Our Journey - Pinnacle Life Science

Pinnacle Lifescience has swiftly acquired a reputation among top cdmo companies in India for its Innovative approach in the world of manufacturing medicine. Quality and Service, led by Innovation has been the roots of our success.

Our Facility

We have built our business as a pharma contract manufacturer in India on the grounds of strong ethics and in compliance with the regulatory boards. We truly believe that great healthcare advances can be made by organisations who understand the need for a more personalised healthcare.

Our Business Verticals

Contract Research

API Development

Contract Manufacturing

Life at Pinnacle

Our diverse and dynamic teams of one of India’s top oncology pharma companies, work globally to bring innovative solutions and ideas to life, while enjoying theirs!

Life at Pinnacle

Pinnacle life science

Our diverse and dynamic teams work globally to bring innovative solutions and ideas to life, while enjoying theirs!

Number of Clients
400
Number of Clients
Countries Exporting To
90+
Countries Exporting To
billion units Tablets
3
billion units Tablets
Million Units Capsules
300
Million Units Capsules

Blogs

British Medical Journal: Extending Rivaroxaban Treatment After Distal DVT Reduces Further Clot Risk

A study published today in The BMJ found that patients who received the anti-clotting medication rivaroxaban for 12 weeks as opposed to the usual 6 weeks after a blood clot in the lower leg had a lower risk of developing …

Does Dapagliflozin Reduce The Risk Of Cardiovascular Death?

It is well established that patients with type-2 diabetes have a higher risk of cardiovascular complications. An exploratory analysis of the DAPA-HF trial data reveals that dapagliflozin treatment is associated with a significant reduction in the risk of cardiovascular death. …

Study: Apixaban Tied To Lower Risk Of Gastrointestinal Bleeding

In medical science, anticoagulants play a significant role. Specific patients require anticoagulants to eliminate blood clots, as blood clots increase the chances of cardiac attacks and cancer. Such situations call for the Apixaban manufacturers. Apixaban is an anticoagulant medicine. It …

How Is The Anti-Cancer Drug Market Prospering At USD 256.66 Billion?

As per the reports, 1 out of 10 men and 1 out of 8 women in India have cancer. After cardiovascular diseases, cancer is the second most prevalent body disorder. While numerous reasons contribute to cancer, the recent shift in …